Results 321 to 330 of about 379,925 (396)

Camrelizumab and apatinib in Chinese patients with locally advanced or metastatic radioiodine-refractory differentiated thyroid cancer: an exploratory open-label, single-arm trial. [PDF]

BMC Med
Zhang X, Sun D, Zhang Y, Mu Z, Shi C, Sun Y, Cheng X, Meng C, Wei X, Liang J, Lin Y.   +10 more
europepmc   +1 more source

Clinical outcome and influencing factors of differentiated thyroid cancer patients with radioiodine-refractory lung metastasis. [PDF]

Front Endocrinol (Lausanne)
Wang C, Li Y, Qin G, Li J, Wang G, Liu X, Wang X.   +6 more
europepmc   +1 more source

From screening to follow-up: a review of quality of life and psychological status across the clinical care continuum in patients with differentiated thyroid cancer. [PDF]

Front Psychol
Kuang Z, Zhao H, Zhang C, Li X.
europepmc   +1 more source

Active Surveillance Versus Thyroid Surgery for Differentiated Thyroid Cancer: A Systematic Review

Thyroid, 2022
Background: Active surveillance has been proposed as an appropriate management strategy for low-risk differentiated thyroid cancer (DTC), due to the typically favorable prognosis of this condition.
R. Chou, T. Dana, M. Haymart, A. Leung, R. Tufano, J. Sosa, M. Ringel   +6 more
semanticscholar   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Thyroid hormone therapy in differentiated thyroid cancer

Endocrine, 2019
Surgery-with or without postoperative radioiodine-is the standard of care for most patients with differentiated thyroid carcinoma (DTC). Thyroid hormone replacement therapy is the mainstay of long-term medical management. Patients treated with total thyroidectomy and some who undergo lobectomy alone require thyroid hormone therapy to restore ...
Giorgio Grani, V. Ramundo, A. Verrienti, M. Sponziello, C. Durante   +4 more
semanticscholar   +3 more sources

Differentiated Thyroid Cancer

DeckerMed CGSO Case-Based Reviews, 2020
R. Tuttle, William Cance, James R. Howe
semanticscholar   +3 more sources

Sex Differences in Differentiated Thyroid Cancer

Thyroid, 2021
Background: Sex dimorphism strongly impacts tumor biology, with most cancers having a male predominance. Uniquely, thyroid cancer (TC) is the only nonreproductive cancer with striking female predominance with three- to four-fold higher incidence among ...
Leila Shobab, K. Burman, L. Wartofsky
semanticscholar   +1 more source